Clinical usefulness of drug-eluting stents in the treatment of dialysis patients with coronary artery disease

EuroIntervention

Volumn 6, Issue 6, 2011, Pages 754-759

  Otsuka, Masaya ^a   Toyofuku, Mamoru ^a   Watanabe, Noriaki ^a   Motoda, Chikaaki ^a   Kawase, Tomoharu ^a   Takeda, Ryo ^a   Mito, Shinji ^a   Tamekiyo, Hiromichi ^a   Okimoto, Tomokazu ^a   Hirao, Hidekazu ^a   Muraoka, Yuji ^a   Ueda, Hironori ^a   Masaoka, Yoshiko ^a   Hayashi, Yasuhiko ^a  

^a TSUCHIYA GENERAL HOSPITAL   (Japan)

Author keywords

Dialysis; Drug eluting stent; Paclitaxel eluting stent; Percutaneous coronary intervention; Sirolimus eluting stent

Indexed keywords

'TAXUS'; ANTITHROMBOCYTIC AGENT; CYPHER; PACLITAXEL; RAPAMYCIN; UNCLASSIFIED DRUG;

ARTICLE; CAUSE OF DEATH; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG FATALITY; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEMODIALYSIS PATIENT; HOSPITALIZATION; HUMAN; HYPERKALEMIA; INFECTION; ISCHEMIC COLITIS; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; REVASCULARIZATION; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; RENAL DIALYSIS; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954523080     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV6I6A128     Document Type: Article

References (26)

1. Best PJ, Lennon R, Ting HH, Bell MR, Rihal CS, Holmes DR, Berger PB. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol 2002;39:1113-9. (Pubitemid 34267412)
2. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002;106:2207-11. (Pubitemid 35222214)
3. Rubenstein MH, Harrell LC, Sheynberg BV, Schunkert H, Bazari H, Palacios IF. Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era? Circulation 2000;102:2966-72.
4. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23. (Pubitemid 37186209)
5. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 2004;109:1942-7. (Pubitemid 38544483)
6. Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients. J Invasive Cardiol 2006;18:577-83. (Pubitemid 46088081)
7. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, Kuroda N, De Gregorio J, Kouno Y, Suzuki M, Haruta S, Komuro I. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007;71:1525-9. (Pubitemid 47529650)
8. Aoyama T, Ishii H, Toriyama T, Takahashi H, Kasuga H, Murakami R, Amano T, Uetani T, Yasuda Y, Yuzawa Y, Maruyama S, Matsuo S, Matsubara T, Murohara T. Sirolimus-eluting stents vs bare metal stents for coronary intervention in Japanese patients with renal failure on hemodialysis. Circ J 2008;72:56-60. (Pubitemid 351413327)
9. Okada T, Hayashi Y, Toyofuku M, Imazu M, Otsuka M, Sakuma T, Ueda H, Yamamoto H, Kohno N. One-year clinical outcomes of dialysis patients after implantation with sirolimus-eluting coronary stents. Circ J 2008;72:1430-5.
10. van der Zwet PM, Pinto IM, Serruys PW, Reiber JH. A new approach for the automated definition of path lines in digitized coronary angiograms. Int J Card Imaging 1990;5:75-83. (Pubitemid 20305570)
11. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King SB, 3rd, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL, Jr., et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 1988;78:486-502.
12. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, Pichard AD, Kent KM, Stone GW, Leon MB. Angiographic patterns of instent restenosis: classification and implications for long-term outcome. Circulation 1999;100:1872-8. (Pubitemid 29511140)
13. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-51. (Pubitemid 46685903)
14. Nakazawa G, Tanabe K, Aoki J, Yamamoto H, Higashikuni Y, Onuma Y, Yachi S, Nakajima H, Hara K. Impact of renal insufficiency on clinical and angiographic outcomes following percutaneous coronary intervention with sirolimus-eluting stents. Catheter Cardiovasc Interv 2007;69:808-14. (Pubitemid 46867481)
15. Halkin A, Mehran R, Casey CW, Gordon P, Matthews R, Wilson BH, Leon MB, Russell ME, Ellis SG, Stone GW. Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: results from the TAXUS-IV Trial. Am Heart J 2005;150:1163-70. (Pubitemid 41773517)
16. Moussa I, Leon MB, Baim DS, O'Neill WW, Popma JJ, Buchbinder M, Midwall J, Simonton CA, Keim E, Wang P, Kuntz RE, Moses JW. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004;109:2273-8. (Pubitemid 38678518)
17. Hermiller JB, Raizner A, Cannon L, Gurbel PA, Kutcher MA, Wong SC, Russell ME, Ellis SG, Mehran R, Stone GW. Outcomes with the polymer-based paclitaxel-eluting TAXUS stent in patients with diabetes mellitus: the TAXUS-IV trial. J Am Coll Cardiol 2005;45:1172-9. (Pubitemid 40523133)
18. Dibra A, Kastrati A, Mehilli J, Pache J, Schuhlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schomig A. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-70. (Pubitemid 41175674)
19. Billinger M, Beutler J, Taghetchian KR, Remondino A, Wenaweser P, Cook S, Togni M, Seiler C, Stettler C, Eberli FR, Luscher TF, Wandel S, Juni P, Meier B, Windecker S. Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients. Eur Heart J 2008;29:718-25. (Pubitemid 351431021)
20. Morice MC, Colombo A, Meier B, Serruys P, Tamburino C, Guagliumi G, Sousa E, Stoll HP. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. Jama 2006;295:895-904.
21. Mayor M, Malik AZ, Minor RJ, Jr., Deshpande MC, Strauss WE, Maloney TH, Baim DS, O'Neill W, Kandzari DE. One-year outcomes from the TAXUS express stent versus cypher stent. Am J Cardiol 2009;103:930-6.
22. Tamekiyo H, Hayashi Y, Toyofuku M, Ueda H, Sakuma T, Okimoto T, Otsuka M, Imazu M, Kihara Y. Clinical outcomes of sirolimus-eluting stenting after rotational atherectomy. Circ J 2009;73:2042-9.
23. Mintz GS, Weissman NJ. Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 2006;48:421-9. (Pubitemid 44093940)
24. Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, Mehran R, Collins M, Leon MB, Popma JJ, Russell ME, Stone GW. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). Am J Cardiol 2005;96:1242-7. (Pubitemid 41505401)
25. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995;332:1004-14.
26. Kimura T, Morimoto T, Nakagawa Y, Tamura T, Kadota K, Yasumoto H, Nishikawa H, Hiasa Y, Muramatsu T, Meguro T, Inoue N, Honda H, Hayashi Y, Miyazaki S, Oshima S, Honda T, Shiode N, Namura M, Sone T, Nobuyoshi M, Kita T, Mitsudo K. Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation. Circulation 2009;119:987-95.